High-tech driving HK IPO market
Print Edition
THREE years after major listing reforms, new economy companies make up the bulk of Hong Kong’s initial public offerings, fueling a new growth story of the global financial hub.
The reforms, which came into force in April 2018, allow pre-revenue biotech companies, new economy firms with weighted voting rights structures, and qualified overseas-listed companies to raise capital in Hong Kong.
By end-March, 146 such companies had listed in Hong Kong since then, raising a total HK$682.2 billion (US$88 billion), or 61 percent of total IPO funds, Hong Kong Exchanges and Clearing Limited said yesterday.
“We are very pleased to see that the introduction of the new listing regime has helped to transform our markets,” said Calvin Tai, HKEX interim chief executive. “HKEX has become the go-to international capital market for new economy companies, and is already the world’s second-biggest biotech fundraising hub.”
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔＄粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
